Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sarah Morin"'
Autor:
Sarah Morin, Filippo Boroli, Sophie Vandenberghe‐Durr, Daniele Allali, Stavroula Masouridi‐Levrat, Yves Chalandon, Federico Simonetta
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 603-606 (2024)
Abstract Anaphylactic reactions at the time of chimeric antigen receptor T (CAR‐T) cell infusion are adverse events that have not been reported in pivotal clinical trials or in real‐world series. We report the case of patient with severe anaphyla
Externí odkaz:
https://doaj.org/article/931fed2a285943d9a4aec227190da80c
Autor:
Federica Giannotti, Carmen De Ramon Ortiz, Federico Simonetta, Sarah Morin, Chiara Bernardi, Stavroula Masouridi-Levrat, Yves Chalandon, Anne-Claire Mamez
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment option for patients with highly chemorefractory Hodgkin lymphoma (HL). The CD30-targeting antibody-drug conjugate Brentuximab-Vedotin (BV) and programm
Externí odkaz:
https://doaj.org/article/cbfb749dbff44cd88f3e883f56499b63
Autor:
Sarah Morin, Federica Giannotti, Anne-Claire Mamez, Amandine Pradier, Stavroula Masouridi-Levrat, Federico Simonetta, Yves Chalandon
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Sorafenib significantly improves survival of FLT3-ITD mutated AML patients when used as a post-allogeneic HSCT maintenance. Importantly, clinical trials reported a low rate of toxicities requiring sorafenib discontinuation. The aim of our analysis wa
Externí odkaz:
https://doaj.org/article/4112719bae8044f9936b6400c0213214
Autor:
Sarah Morin-Zorman, Christian Wysocki, Jieqing Zhu, Hongmei Li, Sylvain Zorman, Catherine Matte-Martone, Edwina Kisanga, Jennifer McNiff, Dhanpat Jain, David Gonzalez, David M. Rothstein, Fadi G. Lakkis, Ann Haberman, Warren D. Shlomchik
Publikováno v:
Blood Advances, Vol 3, Iss 14, Pp 2082-2092 (2019)
Abstract: Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (alloSCT). By static microscopy, cutaneous GVHD lesions contain a mix of T cells and myeloid cells. We used 2
Externí odkaz:
https://doaj.org/article/fd7cc965ad0547689fdd3e6ee81d0457
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT) is a curative treatment for a wide variety of hematological diseases. In 30% of the cases, a geno-identical donor is available. Any other situation displays some level of Human Leukocyte Anti
Externí odkaz:
https://doaj.org/article/6d72b0058c5344868bcfb5f1467726f3
Autor:
Anne-Claire Mamez, Amandine Pradier, Caroline Stephan, Federica Giannotti, Stavroula Masouridi-Levrat, Sarah Morin, Dionysios Neofytos, Diem-Lan Vu, Astrid Melotti, Isabelle Arm-Vernez, Christiane S. Eberhardt, Jerome Tamburini, Laurent Kaiser, Yves Chalandon, Federico Simonetta
Publikováno v:
Blood. 140:10509-10511
Autor:
Romain Samuel Roth, Stavroula Masouridi‐Levrat, Federica Giannotti, Anne‐Claire Mamez, Sarah Morin, Christian van Delden, Yves Chalandon, Dionysios Neofytos
Publikováno v:
Mycoses. 65:1061-1067
Limited data exist to describe end-of-treatment (EOT) parameters of antifungal therapy for invasive mould infections (IMI).In a 10-year cohort of consecutive adult allogeneic haematopoietic cell transplant recipients with proven/probable IMI, we desc
Autor:
Lara Chavaz, Léna Royston, Stavroula Masouridi-Levrat, Anne-Claire Mamez, Federica Giannotti, Sarah Morin, Christian Van Delden, Yves Chalandon, Dionysios Neofytos
Publikováno v:
Open Forum Infectious Diseases. 10
In this single-center study of 61 allogeneic hematopoietic cell transplant (HCT) recipients receiving letermovir primary cytomegalovirus (CMV) prophylaxis for the first 100 days, we report 23% incidence of clinically significant CMV infection during
Autor:
Sarah Morin, Federico Simonetta, Yves Chalandon, Adrien Petitpas, Dominique Clerc-Renaud, Marta Fabra Urdiola, Amandine Pradier, Anne-Claire Mamez, Laurent Kaiser, Christiane S. Eberhardt, Stavroula Masouridi-Levrat, Federica Giannotti, Diem-Lan Vu, Carole Dantin
Publikováno v:
Bone Marrow Transplantation
Autor:
Yves Chalandon, Anne-Claire Mamez, Federica Giannotti, Yan Beauverd, Carole Dantin, Elif Mahne, Maria Mappoura, Fanette Bernard, Carmen de Ramon Ortiz, Caroline Stephan, Sarah Morin, Marc Ansari, Federico Simonetta, Stavroula Masouridi-Levrat
Publikováno v:
Transplantation and Cellular Therapy. 28:765.e1-765.e9
Sinusoidal obstruction syndrome (SOS), also known as hepatic veno-occlusive disease (VOD), is a well-known complication of allogeneic hematopoietic stem cell transplantation (HSCT) associated with a mortality rate of up to 85%. Defibrotide has shown